Inpatient Package to Reduce HIV and AIDS-related Death in Zambia
IPADZ
1 other identifier
interventional
72
1 country
1
Brief Summary
Early post-discharge mortality is high among HIV-infected Zambians admitted to the hospital. Likely this is in part due to missed opportunities to identify lethal coinfections and optimize HIV care during admission (and before discharge). In this study the investigators will develop and pilot a new approach to inpatient HIV care that follows international guidelines for management of advanced HIV disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 23, 2019
CompletedFirst Posted
Study publicly available on registry
July 26, 2019
CompletedStudy Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedAugust 9, 2024
August 1, 2024
2.7 years
July 23, 2019
August 6, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Coinfection diagnosis
Positive test for tuberculosis or cryptococcus on admission
Through hospital discharge, an average of 2 weeks
Study Arms (2)
Inpatient lab bundling plus navigation
EXPERIMENTALTesting for CD4 count, tuberculosis, cryptococcus, and HIV RNA with samples collected in a bundle-type approach. Additional inpatient support from a patient navigator
Inpatient lab bundling alone
EXPERIMENTALTesting for CD4 count, tuberculosis, cryptococcus, and HIV RNA with samples collected in a bundle-type approach.
Interventions
The investigators will provide patients a package of diagnostic tests at the time of admission to comprehensively assess for HIV coinfections and treatment failure. These labs are all recommended in advanced HIV guidelines but in this study we will provide all tests as a bundle rather than step-by-step as suggested in guidelines.
Participants will be assigned a patient navigator who will support the patient and bedsider (treatment supporter/guardian) during the hospitalization. The navigator will be an HIV counselor who can provide counseling and health education, as well as support specimen transport, obtaining results, booking tests in other departments, linkages to ART clinic, and discharge planning
Eligibility Criteria
You may qualify if:
- + years old
- HIV-positive (by self-report or DCT result in UTH file)
- Resident of Lusaka
- Admitted to the hospital
You may not qualify if:
- Too sick to provide informed consent (based on clinician opinion)
- Likely to be discharged in the next 48 hours (based on clinician opinion)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Alabama at Birminghamlead
- University Teaching Hospitalcollaborator
- University of Marylandcollaborator
Study Sites (1)
University Teaching Hospital
Lusaka, Zambia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael J Vinikoor, MD
Assistant Professor of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 23, 2019
First Posted
July 26, 2019
Study Start
October 1, 2021
Primary Completion
June 30, 2024
Study Completion
June 30, 2024
Last Updated
August 9, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share